Search research articles
Contact Us
Filters
Showing results (981-990 of 999) with videos related to
Page
of 100
Sort By:
Brain : a Journal of Neurology
|
May 9, 2015
Existing Pittsburgh Compound-B positron emission tomography thresholds are too high: statistical and pathological evaluation
Sylvia Villeneuve, Gil D Rabinovici, Brendan I Cohn-Sheehy, et al.
Academic Radiology
|
October 28, 2020
Online Liver Imaging Course; Pivoting to Transform Radiology Education During the SARS-CoV-2 Pandemic
Khaled M Elsayes, Robert M Marks, Serageldin Kamel, et al.
Cancer Cell
|
January 15, 2021
MAT2A Inhibition Blocks the Growth of MTAP-Deleted Cancer Cells by Reducing PRMT5-Dependent mRNA Splicing and Inducing DNA Damage
Peter Kalev, Marc L Hyer, Stefan Gross, et al.
Nature Communications
|
January 11, 2019
A chemical biology screen identifies a vulnerability of neuroendocrine cancer cells to SQLE inhibition
Christopher E Mahoney, David Pirman, Victor Chubukov, et al.
The New England Journal of Medicine
|
May 28, 2020
Remdesivir for 5 or 10 Days in Patients with Severe Covid-19
Jason D Goldman, David C B Lye, David S Hui, et al.
Nature
|
July 16, 2011
Functional genomics reveal that the serine synthesis pathway is essential in breast cancer
Richard Possemato, Kevin M Marks, Yoav D Shaul, et al.
Brain : a Journal of Neurology
|
September 2, 2009
Molecular basis of infantile reversible cytochrome c oxidase deficiency myopathy
Rita Horvath, John P Kemp, Helen A L Tuppen, et al.
Surgical Endoscopy
|
December 18, 2022
Multi-society consensus conference and guideline on the treatment of gastroesophageal reflux disease (GERD)
Bethany J Slater, Amelia Collings, Rebecca Dirks, et al.
Endoscopy
|
November 16, 2020
Management of patients after failed peroral endoscopic myotomy: a multicenter study
Yervant Ichkhanian, Daniella Assis, Pietro Familiari, et al.
Molecular Cancer Therapeutics
|
October 21, 2020
Selective Vulnerability to Pyrimidine Starvation in Hematologic Malignancies Revealed by AG-636, a Novel Clinical-Stage Inhibitor of Dihydroorotate Dehydrogenase
Gabrielle McDonald, Victor Chubukov, John Coco, et al.
Page
of 100
Search research articles
Search
Showing results (981-990 of 999) with videos related to
Sort By:
Page
of 100
Brain : a Journal of Neurology
|
May 9, 2015
Existing Pittsburgh Compound-B positron emission tomography thresholds are too high: statistical and pathological evaluation
Sylvia Villeneuve, Gil D Rabinovici, Brendan I Cohn-Sheehy, et al.
Academic Radiology
|
October 28, 2020
Online Liver Imaging Course; Pivoting to Transform Radiology Education During the SARS-CoV-2 Pandemic
Khaled M Elsayes, Robert M Marks, Serageldin Kamel, et al.
Cancer Cell
|
January 15, 2021
MAT2A Inhibition Blocks the Growth of MTAP-Deleted Cancer Cells by Reducing PRMT5-Dependent mRNA Splicing and Inducing DNA Damage
Peter Kalev, Marc L Hyer, Stefan Gross, et al.
Nature Communications
|
January 11, 2019
A chemical biology screen identifies a vulnerability of neuroendocrine cancer cells to SQLE inhibition
Christopher E Mahoney, David Pirman, Victor Chubukov, et al.
The New England Journal of Medicine
|
May 28, 2020
Remdesivir for 5 or 10 Days in Patients with Severe Covid-19
Jason D Goldman, David C B Lye, David S Hui, et al.
Nature
|
July 16, 2011
Functional genomics reveal that the serine synthesis pathway is essential in breast cancer
Richard Possemato, Kevin M Marks, Yoav D Shaul, et al.
Brain : a Journal of Neurology
|
September 2, 2009
Molecular basis of infantile reversible cytochrome c oxidase deficiency myopathy
Rita Horvath, John P Kemp, Helen A L Tuppen, et al.
Surgical Endoscopy
|
December 18, 2022
Multi-society consensus conference and guideline on the treatment of gastroesophageal reflux disease (GERD)
Bethany J Slater, Amelia Collings, Rebecca Dirks, et al.
Endoscopy
|
November 16, 2020
Management of patients after failed peroral endoscopic myotomy: a multicenter study
Yervant Ichkhanian, Daniella Assis, Pietro Familiari, et al.
Molecular Cancer Therapeutics
|
October 21, 2020
Selective Vulnerability to Pyrimidine Starvation in Hematologic Malignancies Revealed by AG-636, a Novel Clinical-Stage Inhibitor of Dihydroorotate Dehydrogenase
Gabrielle McDonald, Victor Chubukov, John Coco, et al.
Page
of 100